Global pharma powerhoutilize Eli Lilly and Incyte have announced a major regulatory milestone today: the European Medicines Agency’s (EMA) Committee…
Read More
Celltrion acquires Eli Lilly’s New Jersey plant for $330 million
Celltrion Inc. confirmed Tuesday it has agreed to acquire Eli Lilly and Company’s plant in Branchburg, NJ, for about 460…
Read More
Eli Lilly stock slides, Pinterest sells off, Expedia and Block gain after hours
Crocs (CROX) forecast a 9% to 11% decline in third quarter revenue on Thursday, as tariffs and a softer consumer…
Read More
Eli Lilly lands “bargain” deal to acquire Verve Therapeutics for $1.3bn
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising to $1.3bn, with…
Read More
